Project 3: Role of pregnane X receptor in diet-induced obesity and metabolic syndrome

项目3：孕烷X受体在饮食引起的肥胖和代谢综合征中的作用

• 批准号: 9750533
• 负责人: Maxwell Afari Gyamfi
• 金额: $ 32.76万
• 依托单位: NORTH CAROLINA CENTRAL UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9750533
• 关键词: Adipose tissue; Affect; African American; Age; Alleles; Attenuated; Beta Cell; Bioinformatics; Biological Assay; Blood; Cardiovascular Diseases; Caucasians; Characteristics; Chemicals; Chronic Disease; Complex; Data; Development; Diabetes Mellitus; Diet; Disease; Epidemic; Exhibits; Female; Frequencies; Gender; Gene Frequency; Genes; Genetic; Genetic Models; Genetic Polymorphism; Genetic Transcription; Genome; Genomic DNA; Genotype; Glucokinase; Glucose; Glucose Intolerance; Goals; Gonadal Steroid Hormones; High Fat Diet; Homeostasis; Human; Hyperglycemia; Hypertension; Impairment; Ingestion; Insulin Resistance; Intestines; Kansas; Knock-out; Knockout Mice; Link; Lipids; Liver; Matched Group; Measures; Medical center; Metabolic; Metabolic syndrome; Molecular; Mus; Non-Insulin-Dependent Diabetes Mellitus; Not Hispanic or Latino; Nuclear Receptors; Obesity; Pathway interactions; Patients; Phenotype; Plasma; Pregnenolone; Prevention strategy; Proteins; RNA; Receptor Gene; Regulation; Regulator Genes; Research; Resistance; Risk; Rodent; Role; Sampling; Serum; Sex Differences; Signal Transduction; Signal Transduction Pathway; Single Nucleotide Polymorphism; Soleus Muscle; Tissue Banks; Tissue Sample; Tissues; Transgenic Organisms; Universities; Variant; Weight Gain; Wild Type Mouse; Woman; Xenobiotics; adipokines; adiponectin; base; cardiovascular health; clinically relevant; deep sequencing; diagnostic biomarker; ethnic difference; experimental study; fasting glucose; feeding; genetic variant; glucose metabolism; health disparity; hormone metabolism; humanized mouse; impaired glucose tolerance; insight; insulin sensitivity; lipid metabolism; liver biopsy; male; men; mouse model; novel; novel diagnostics; obesity development; obesity risk; obesity treatment; pregnane X receptor; racial difference; racial disparity; receptor expression; sex; targeted treatment; therapeutic target; transcriptome; treatment strategy

Abstract Metabolic syndrome, driven mainly by obesity is a global epidemic that increases the risk of several chronic diseases including type 2 diabetes (T2D). T2D is prevalent in male and female African Americans (AAs) of all ages. Low plasma levels of adiponectin, a protein secreted by adipose tissue are implicated in the development of T2D in obese AAs. Although, initially characterized as a xenobiotic nuclear receptor important for defense against toxic agents, the pregnane X receptor (PXR) appears to be linked to lipid and glucose metabolism contributing to the metabolic syndrome epidemic. We find that the impact of PXR on HFD-induced obesity and hyperglycemia is sex- and species-dependent. However, the specific mechanisms linking PXR to these diseases remain unclear. Thus, our long term goal is to identify ethnic- and sex- specific targets for lipid-associated diseases (such as obesity and T2D) that disproportionately threaten cardiovascular health in AAs, to develop novel prevention and treatment strategies. The objectives of our proposal are: 1) to investigate whether PXR polymorphisms, more common in AAs are associated with known increases in obesity risk and 2) to understand the underlying molecular mechanisms by which the PXR gene and/or its variants regulate lipid, glucose, and sex hormone metabolism, leading to either enhanced obesity or T2D upon HFD feeding. Guided by compelling preliminary data, our central hypothesis is that PXR deficiency results in impaired adiponectin signaling leading to insulin resistance and glucose intolerance with more prominent race and sex differences. We will use human blood and liver tissue samples and 3 genetic models of mice with differential PXR activity (wild type, PXR-knockout, and PXR-humanized mice), along with molecular and cellular studies. Aim 1 investigates the effect of the human PXR gene and its polymorphisms on obesity risk in AAs. Aim 2 determines the genetic and metabolic factors that contribute to resistance to HFD- induced obesity in Pxr-null mice. Aim 3 explores the relationship between obesity-induced diabetes and hypoadiponectinemia in mice with different PXR activity. Our studies are novel in using clinically relevant PXR-humanized (hPXR) mice to characterize function and regulation of PXR. This study is significant in providing valuable insights in similarities and differences in phenotypic expression and signal transduction pathways between the mouse PXR and the human PXR gene in contributing to the development of obesity and T2D in the different genders. Our studies should provide ground-breaking advances into pathways that can be targeted for the treatment of obesity and metabolic syndrome in AAs.

摘要 代谢综合征主要由肥胖引起，是一种全球流行病， 包括2型糖尿病（T2 D）在内的几种慢性疾病。T2 D在男性和女性中普遍存在 所有年龄段的非洲裔美国人（AAs）。低血浆脂联素水平，脂联素是由 脂肪组织与肥胖AA中T2 D的发展有关。虽然，最初 其特征在于作为一种异生物质核受体，对于防御有毒物质是重要的， 孕烷X受体（PXR）似乎与脂质和葡萄糖代谢有关，有助于 代谢综合征的流行我们发现PXR对HFD诱导的肥胖的影响， 高血糖症具有性别和物种依赖性。然而，连接PXR的具体机制 这些疾病的病因尚不清楚。因此，我们的长期目标是确定种族和性别- 脂质相关疾病（如肥胖症和T2 D）的特异性靶点， 威胁AA的心血管健康，开发新的预防和治疗策略。 我们的目标是：1）研究PXR多态性， 常见于AA与已知的肥胖风险增加有关，2）了解 PXR基因和/或其变体调节脂质的潜在分子机制， 葡萄糖和性激素代谢，导致HFD后肥胖或T2 D增强 喂食在令人信服的初步数据的指导下，我们的中心假设是PXR 缺乏导致脂联素信号传导受损，导致胰岛素抵抗， 葡萄糖耐受不良与更突出的种族和性别差异。我们将使用人类 血液和肝组织样品和3种具有不同PXR活性的小鼠遗传模型（野生型 型、PXR敲除和PXR人源化小鼠），沿着分子和细胞研究。目的 1研究人类PXR基因及其多态性对AA肥胖风险的影响。 目的2确定有助于耐HFD的遗传和代谢因素- 诱导的肥胖。目的3探讨肥胖诱导的 糖尿病和低脂联素血症的小鼠与不同的PXR活性。我们的研究是新颖的， 使用临床相关的PXR人源化（hPXR）小鼠来表征 PXR。本研究对揭示中国传统文化的异同具有重要意义。 表型表达和信号转导途径之间的小鼠PXR和 人类PXR基因在不同人群中促进肥胖和T2 D的发展 性别我们的研究应该提供突破性的进展， 靶向治疗AA中的肥胖和代谢综合征。